Zobrazeno 1 - 10
of 476
pro vyhledávání: '"Jeremy M Shefner"'
Autor:
Suloma, Cy
Publikováno v:
International Social Science Review, 1982 Jan 01. 57(1), 60-61.
Externí odkaz:
https://www.jstor.org/stable/41881290
Autor:
Sudarshan Ragunathan, Laura C. Bell, Natenael Semmineh, Ashley M. Stokes, Jeremy M. Shefner, Robert Bowser, Shafeeq Ladha, C. Chad Quarles
Publikováno v:
Tomography, Vol 7, Iss 2, Pp 169-179 (2021)
(1) Background: This work characterizes the sensitivity of magnetic resonance-based Relaxivity Contrast Imaging (RCI) to Amyotrophic Lateral Sclerosis (ALS)-induced changes in myofiber microstructure. Transverse Relaxivity at Tracer Equilibrium (TRAT
Externí odkaz:
https://doaj.org/article/088c529e03844d5e9688cf5d0497b304
Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis
Autor:
Hagit Goldshtein, Alexandre Muhire, Virginie Petel Légaré, Avital Pushett, Ron Rotkopf, Jeremy M. Shefner, Randall T Peterson, Gary A. B. Armstrong, Niva Russek‐ Blum
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 10, Pp 1883-1897 (2020)
Abstract Objective To evaluate the efficacy of a fixed‐dose combination of two approved drugs, Ciprofloxacin and Celecoxib, as a potential therapeutic treatment for amyotrophic lateral sclerosis (ALS). Methods Toxicity and efficacy of Ciprofloxacin
Externí odkaz:
https://doaj.org/article/b113a40b6b6d4087b0de396e6c9a5c30
Autor:
Seward B. Rutkove, Pushpa Narayanaswami, Visar Berisha, Julie Liss, Shira Hahn, Kerisa Shelton, Kristin Qi, Sarbesh Pandeya, Jeremy M. Shefner
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 7, Pp 1148-1157 (2020)
Abstract Objective To determine the potential for improving amyotrophic lateral sclerosis (ALS) clinical trials by having patients or caregivers perform frequent self‐assessments at home. Methods and Participants We enrolled ALS patients into a non
Externí odkaz:
https://doaj.org/article/2bc2d97ad7844db7a02addd94b6b29fd
Autor:
Jeremy M. Shefner, Ammar Al-Chalabi, Jinsy A. Andrews, Adriano Chio, Mamede De Carvalho, Bettina M. Cockroft, Philippe Corcia, Philippe Couratier, Merit E. Cudkowicz, Angela Genge, Orla Hardiman, Terry Heiman-Patterson, Robert D. Henderson, Caroline Ingre, Carlayne E. Jackson, Wendy Johnston, Noah Lechtzin, Albert Ludolph, Nicholas J. Maragakis, Timothy M. Miller, Jesus S. Mora Pardina, Susanne Petri, Zachary Simmons, Leonard H. Van Den Berg, Lorne Zinman, Stuart Kupfer, Fady I. Malik, Lisa Meng, Tyrell J. Simkins, Jenny Wei, Andrew A. Wolff, Stacy A. Rudnicki
Publikováno v:
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. :1-12
Autor:
Paulos Gebrehiwet, Lisa Meng, Stacy A. Rudnicki, Phil Sarocco, Jenny Wei, Andrew A. Wolff, Michael Butzner, Adriano Chiò, Jinsy A. Andrews, Angela Genge, Dyfrig A. Hughes, Carlayne E. Jackson, Noah Lechtzin, Timothy M. Miller, Jeremy M. Shefner
Publikováno v:
Journal of Medical Economics. 26:488-493
Autor:
Shiran, Salomon-Zimri, Avital, Pushett, Niva, Russek-Blum, Ruben P A, Van Eijk, Nurit, Birman, Beatrice, Abramovich, Erez, Eitan, Katya, Elgrart, Danielle, Beaulieu, David L, Ennist, James D, Berry, Sabrina, Paganoni, Jeremy M, Shefner, Vivian E, Drory
Publikováno v:
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 24:263-271
Autor:
Seward B. Rutkove, Pushpa Narayanaswami, Visar Berisha, Julie Liss, Shira Hahn, Kerisa Shelton, Kristin Qi, Sarbesh Pandeya, Jeremy M. Shefner
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 10, Pp 2076-2077 (2020)
Externí odkaz:
https://doaj.org/article/975c450513e043aba12efe9c59848380
Autor:
Paulos Gebrehiwet, Lisa Meng, Stacy A. Rudnicki, Phil Sarocco, Jenny Wei, Andrew A. Wolff, Adriano Chiò, Jinsy A. Andrews, Angela Genge, Carlayne E. Jackson, Noah Lechtzin, Timothy M. Miller, Jeremy M. Shefner
Publikováno v:
Amyotrophic lateral sclerosisfrontotemporal degeneration.
Autor:
Elena Ratti, James D. Berry, David J. Greenblatt, Lorena Loci, Amy Swartz Ellrodt, Jeremy M. Shefner, Merit E. Cudkowicz
Publikováno v:
Toxicology Reports, Vol 2, Iss C, Pp 1396-1403 (2015)
A 6-months rodent toxicology and pharmacokinetic (PK) study was performed to provide supportive safety data for long-term use of intravenous ceftriaxone in a clinical trial in patients with amyotrophic lateral sclerosis (ALS). Ceftriaxone was adminis
Externí odkaz:
https://doaj.org/article/995e71aa7ad644fdacb723b711f93452